Quick ViewRegenerative Blend
GLOW
From$114.99
Cellular Peptide
BPC-157
Body Protection Compound-157PL-14736PLD-116Bepecin
A 15-amino acid peptide derived from human gastric juice that demonstrates protection and regenerative effects in animal cell models. Premium Research Peptide.
Dosage
Third-Party TestingIdentity, purity, and batch consistency reviewed by an independent lab.
$39.99
Bundle & Save
1
Estimated delivery Mon, May 11 – Sun, May 17
Free shipping on orders over $99
Free shipment protection · Lost, damaged, stolen — we replace it.
Overnight shipping available
Research use only. Not for human consumption. Sold exclusively for qualified research.
Similar research products
Based on the current compound category and related research focus.
- Quick View
- Quick View
Regenerative Peptide Blend
KLOW
From$129.99
- Quick View
Anti-Inflammatory Peptide
KPV
From$39.99
Third-Party Testing
We use third-party testing to give you a clearer look at identity, purity, and batch consistency before a product reaches your lab. Our testing is done by Freedom Diagnostics.
We use HPLC and/or Mass Spectrometry to make sure the peptide is what it says it is, with a clear look at purity and any major impurities we would want you to know about.
This helps us understand how much actual peptide is in the vial, separate from things like water, salts, or counterions, so the batch information is more useful and honest.
We check for bacterial endotoxins because cleaner documentation matters, especially for researchers working with sensitive cell culture or in vivo settings.
Additional vials from the same lot can be compared against the primary sample, giving another layer of confidence that the batch is consistent from vial to vial.
Certificate of Analysis Documents
- LatestView99.11%Purity
- Variant
- BPC-157 10mg
- Lot #
- P0142
- Labeled
- 10mg
- Actual
- 11.65mg
- Tested
- Feb 4, 2026
Compound Information
Reference details for molecular identification, handling conditions, and storage guidance.
Molecular Profile
- Type
- Synthetic pentadecapeptide
- CAS Number
- 137525-51-0
- Molecular Weight
- 1419.5 g/mol
- Amino Acids
- 15
- Sequence
- GEPPPGKPADDAGLV
- Formula
- C₆₂H₉₈N₁₆O₂₂
Stability & Storage
- Room temp stable (short-term)
- Protect from light
- Resistant to enzymatic degradation
- Lyophilized (powder)-20°C/stable
- Reconstituted2-8°C/use within 30 days
- Gastric stability24+ hours in gastric juice
Clinical & preclinical references
Peer-reviewed studies referenced for educational purposes only. Not intended as medical advice or product claims.
HSS Journal (NIH/PubMed Central)
Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review
Vasireddi N, Hahamyan H, Salata MJ, Karns M, Calcei JG, Voos JE, Apostolakos JM
2025 / PMID 40756949 / DOI 10.1177/15563316251355551
View Source
Journal of Applied Physiology
The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration
Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH
2011 / PMID 21030672 / DOI 10.1152/japplphysiol.00945.2010
View Source
Scientific Reports (Nature)
Modulatory effects of BPC 157 on vasomotor tone and the Src-Cav-1-eNOS signaling pathway in rats
Hsieh MJ, Lee CH, Chueh HY, et al.
2020 / PMID 33046803 / DOI 10.1038/s41598-020-74022-y
View Source
Frontiers in Pharmacology
Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs
He L, Feng D, Guo H, et al.
2022 / DOI 10.3389/fphar.2022.1026182
View Source
Current Neuropharmacology
Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications
Sikiric P, Seiwerth S, Rucman R, et al.
2016 / PMID 27138887 / DOI 10.2174/1570159x13666160502153022
View Source
ClinicalTrials.gov
PCO-02 — Safety and Pharmacokinetics Trial (Phase 1)
2015
View Source
HSS Journal (NIH/PubMed Central)
Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review
Vasireddi N, Hahamyan H, Salata MJ, Karns M, Calcei JG, Voos JE, Apostolakos JM
2025 / PMID 40756949 / DOI 10.1177/15563316251355551
View Source
Journal of Applied Physiology
The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration
Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH
2011 / PMID 21030672 / DOI 10.1152/japplphysiol.00945.2010
View Source
Scientific Reports (Nature)
Modulatory effects of BPC 157 on vasomotor tone and the Src-Cav-1-eNOS signaling pathway in rats
Hsieh MJ, Lee CH, Chueh HY, et al.
2020 / PMID 33046803 / DOI 10.1038/s41598-020-74022-y
View Source
Frontiers in Pharmacology
Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs
He L, Feng D, Guo H, et al.
2022 / DOI 10.3389/fphar.2022.1026182
View Source
Current Neuropharmacology
Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications
Sikiric P, Seiwerth S, Rucman R, et al.
2016 / PMID 27138887 / DOI 10.2174/1570159x13666160502153022
View Source
ClinicalTrials.gov
PCO-02 — Safety and Pharmacokinetics Trial (Phase 1)
2015
View Source
HSS Journal (NIH/PubMed Central)
Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review
Vasireddi N, Hahamyan H, Salata MJ, Karns M, Calcei JG, Voos JE, Apostolakos JM
2025 / PMID 40756949 / DOI 10.1177/15563316251355551
View Source
Journal of Applied Physiology
The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration
Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH
2011 / PMID 21030672 / DOI 10.1152/japplphysiol.00945.2010
View Source
Scientific Reports (Nature)
Modulatory effects of BPC 157 on vasomotor tone and the Src-Cav-1-eNOS signaling pathway in rats
Hsieh MJ, Lee CH, Chueh HY, et al.
2020 / PMID 33046803 / DOI 10.1038/s41598-020-74022-y
View Source
Frontiers in Pharmacology
Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs
He L, Feng D, Guo H, et al.
2022 / DOI 10.3389/fphar.2022.1026182
View Source
Current Neuropharmacology
Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications
Sikiric P, Seiwerth S, Rucman R, et al.
2016 / PMID 27138887 / DOI 10.2174/1570159x13666160502153022
View Source
ClinicalTrials.gov
PCO-02 — Safety and Pharmacokinetics Trial (Phase 1)
2015
View Source
HSS Journal (NIH/PubMed Central)
Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review
Vasireddi N, Hahamyan H, Salata MJ, Karns M, Calcei JG, Voos JE, Apostolakos JM
2025 / PMID 40756949 / DOI 10.1177/15563316251355551
View Source
Journal of Applied Physiology
The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration
Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH
2011 / PMID 21030672 / DOI 10.1152/japplphysiol.00945.2010
View Source
Scientific Reports (Nature)
Modulatory effects of BPC 157 on vasomotor tone and the Src-Cav-1-eNOS signaling pathway in rats
Hsieh MJ, Lee CH, Chueh HY, et al.
2020 / PMID 33046803 / DOI 10.1038/s41598-020-74022-y
View Source
Frontiers in Pharmacology
Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs
He L, Feng D, Guo H, et al.
2022 / DOI 10.3389/fphar.2022.1026182
View Source
Current Neuropharmacology
Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications
Sikiric P, Seiwerth S, Rucman R, et al.
2016 / PMID 27138887 / DOI 10.2174/1570159x13666160502153022
View Source
ClinicalTrials.gov
PCO-02 — Safety and Pharmacokinetics Trial (Phase 1)
2015
View Source
HSS Journal (NIH/PubMed Central)
Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review
Vasireddi N, Hahamyan H, Salata MJ, Karns M, Calcei JG, Voos JE, Apostolakos JM
2025 / PMID 40756949 / DOI 10.1177/15563316251355551
View Source
Journal of Applied Physiology
The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration
Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH
2011 / PMID 21030672 / DOI 10.1152/japplphysiol.00945.2010
View Source
Scientific Reports (Nature)
Modulatory effects of BPC 157 on vasomotor tone and the Src-Cav-1-eNOS signaling pathway in rats
Hsieh MJ, Lee CH, Chueh HY, et al.
2020 / PMID 33046803 / DOI 10.1038/s41598-020-74022-y
View Source
Frontiers in Pharmacology
Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs
He L, Feng D, Guo H, et al.
2022 / DOI 10.3389/fphar.2022.1026182
View Source
Current Neuropharmacology
Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications
Sikiric P, Seiwerth S, Rucman R, et al.
2016 / PMID 27138887 / DOI 10.2174/1570159x13666160502153022
View Source
ClinicalTrials.gov
PCO-02 — Safety and Pharmacokinetics Trial (Phase 1)
2015
View Source
HSS Journal (NIH/PubMed Central)
Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review
Vasireddi N, Hahamyan H, Salata MJ, Karns M, Calcei JG, Voos JE, Apostolakos JM
2025 / PMID 40756949 / DOI 10.1177/15563316251355551
View Source
Journal of Applied Physiology
The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration
Chang CH, Tsai WC, Lin MS, Hsu YH, Pang JH
2011 / PMID 21030672 / DOI 10.1152/japplphysiol.00945.2010
View Source
Scientific Reports (Nature)
Modulatory effects of BPC 157 on vasomotor tone and the Src-Cav-1-eNOS signaling pathway in rats
Hsieh MJ, Lee CH, Chueh HY, et al.
2020 / PMID 33046803 / DOI 10.1038/s41598-020-74022-y
View Source
Frontiers in Pharmacology
Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs
He L, Feng D, Guo H, et al.
2022 / DOI 10.3389/fphar.2022.1026182
View Source
Current Neuropharmacology
Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications
Sikiric P, Seiwerth S, Rucman R, et al.
2016 / PMID 27138887 / DOI 10.2174/1570159x13666160502153022
View Source
ClinicalTrials.gov
PCO-02 — Safety and Pharmacokinetics Trial (Phase 1)
2015
View Source
Research Use Only
Important Research Notice
Not for human consumption. This product is sold exclusively for research and educational purposes. It is not intended to diagnose, treat, cure, or prevent any disease.
Clinical trial data and research findings on this page are sourced from peer-reviewed journals and official publications. They are provided for educational reference only and should not be interpreted as medical advice or product claims.
By purchasing this product, you confirm that you are a qualified researcher and will use it in accordance with all applicable laws and regulations.